Skip to main content
SpringerLink
Log in

Complex hypodiploid acute myeloid leukaemia secondary to chemotherapy for hyperdiploid multiple myeloma

  • Images in Hematology
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Munshi NC, Avet-Loiseau H. Genomics in multiple myeloma. Clin Cancer Res. 2011;17:1234–42.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Avet-Loiseau H, Li C, Magrangeas F, et al. Prognostic significance of copy-number alterations in multiple myeloma. J Clin Oncol. 2009;27:4585–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Chng WJ, Santana-Davila R, Van Wier SA, et al. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations. Leukemia. 2006;20:807–13.

    Article  CAS  PubMed  Google Scholar 

  4. Kumar S, Fonseca R, Ketterling RP, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 2012;119:2100–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Yang J, Terebelo HR, Zonder JA. Secondary primary malignancies in multiple myeloma: an old NEMESIS revisited. Adv Hematol. 2012;2012:801495.

    PubMed Central  PubMed  Google Scholar 

  6. Reddi DM, Lu CM, Fedoriw G, et al. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens. Am J Clin Pathol. 2012;138:855–66.

    Article  CAS  PubMed  Google Scholar 

  7. Mailankody S, Pfeiffer RM, Kristinsson SY, et al. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood. 2011;118:4086–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Vardiman JW, Arber DA, Brunning RD, et al. Therapy related myeloid neoplasm. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 127–9.

    Google Scholar 

Download references

Conflict of interest

None to disclose for both authors.

Author information

Authors and Affiliations

  1. Haematology Department, Launceston General Hospital, Launceston, Australia

    Muhajir Mohamed

  2. Launceston Clinical School, University of Tasmania, Hobart, Australia

    Muhajir Mohamed

  3. Cytogenetics Department, Royal Hobart Hospital, Hobart, Australia

    Karen Dun

Authors
  1. Muhajir Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen Dun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Muhajir Mohamed.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohamed, M., Dun, K. Complex hypodiploid acute myeloid leukaemia secondary to chemotherapy for hyperdiploid multiple myeloma. Int J Hematol 100, 3–6 (2014). https://doi.org/10.1007/s12185-014-1594-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-014-1594-y

Keywords

Search

Navigation